{"id":"https://openalex.org/W3203758519","doi":"https://doi.org/10.1007/s00417-021-05224-x","title":"Disease-modifying effects of ranibizumab for central retinal vein occlusion","display_name":"Disease-modifying effects of ranibizumab for central retinal vein occlusion","publication_year":2021,"publication_date":"2021-10-06","ids":{"openalex":"https://openalex.org/W3203758519","doi":"https://doi.org/10.1007/s00417-021-05224-x","mag":"3203758519","pmid":"https://pubmed.ncbi.nlm.nih.gov/34613454","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8850212"},"language":"en","primary_location":{"id":"doi:10.1007/s00417-021-05224-x","doi":"https://doi.org/10.1007/s00417-021-05224-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00417-021-05224-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00417-021-05224-x.pdf","source":{"id":"https://openalex.org/S93410275","display_name":"Graefe s Archive for Clinical and Experimental Ophthalmology","issn_l":"0721-832X","issn":["0721-832X","1435-702X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Graefe's Archive for Clinical and Experimental Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00417-021-05224-x.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058468857","display_name":"Jason Mingyi Huang","orcid":"https://orcid.org/0000-0001-7078-2894","observed_orcids":["https://orcid.org/0000-0001-7078-2894"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason M. Huang","raw_affiliation_strings":["University of California Los Angeles Stein Eye Institute, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California Los Angeles Stein Eye Institute, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051317487","display_name":"Rahul N. Khurana","orcid":"https://orcid.org/0000-0001-5198-1353","observed_orcids":["https://orcid.org/0000-0001-5198-1353"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rahul N. Khurana","raw_affiliation_strings":["Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA","Northern California Retina Vitreous Associates, Mountain View, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Northern California Retina Vitreous Associates, Mountain View, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077249261","display_name":"Avanti Ghanekar","orcid":"https://orcid.org/0000-0001-9972-9675","observed_orcids":["https://orcid.org/0000-0001-9972-9675"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Avanti Ghanekar","raw_affiliation_strings":["Genentech Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041378794","display_name":"Pin-wen Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pin-wen Wang","raw_affiliation_strings":["Genentech Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112431286","display_name":"Bann-mo Day","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bann-Mo Day","raw_affiliation_strings":["Genentech Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109414459","display_name":"Barbara A. Blodi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara A. Blodi","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049198875","display_name":"Amitha Domalpally","orcid":"https://orcid.org/0000-0002-8145-9619","observed_orcids":["https://orcid.org/0000-0002-8145-9619"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amitha Domalpally","raw_affiliation_strings":["Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology and Visual Sciences, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022744977","display_name":"Carlos Quezada-Ruiz","orcid":"https://orcid.org/0000-0002-9909-6553","observed_orcids":["https://orcid.org/0000-0002-9909-6553"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Quezada-Ruiz","raw_affiliation_strings":["Genentech Inc, South San Francisco, CA, USA","Retina Y Vitreo, Clinica de Ojos de La Garza Viejo, San Pedro Garza Garcia, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Retina Y Vitreo, Clinica de Ojos de La Garza Viejo, San Pedro Garza Garcia, Mexico","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017043678","display_name":"Michael S. Ip","orcid":"https://orcid.org/0000-0003-1304-4101","observed_orcids":["https://orcid.org/0000-0003-1304-4101"]},"institutions":[{"id":"https://openalex.org/I4210095445","display_name":"Doheny Eye Institute","ror":"https://ror.org/00qvx5329","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210095445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael S. Ip","raw_affiliation_strings":["Doheny Eye Institute, 800 South Fairmont Avenue, Pasadena, CA, 91105, USA. mip@doheny.org","Doheny Eye Institute, 800 South Fairmont Avenue, Pasadena, CA, 91105, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Doheny Eye Institute, 800 South Fairmont Avenue, Pasadena, CA, 91105, USA. mip@doheny.org","institution_ids":["https://openalex.org/I4210095445"]},{"raw_affiliation_string":"Doheny Eye Institute, 800 South Fairmont Avenue, Pasadena, CA, 91105, USA","institution_ids":["https://openalex.org/I4210095445"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5017043678"],"corresponding_institution_ids":["https://openalex.org/I4210095445"],"apc_list":{"value":3860,"currency":"USD","value_usd":3860},"apc_paid":{"value":3860,"currency":"USD","value_usd":3860},"fwci":0.6381,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.64796804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"260","issue":"3","first_page":"799","last_page":"805"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/central-retinal-vein-occlusion","display_name":"central retinal vein occlusion","score":1.0},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.921999990940094},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/disease-modification","display_name":"disease modification","score":0.9100000262260437},{"id":"https://openalex.org/keywords/retinal-hemorrhage","display_name":"retinal hemorrhage","score":0.9200000166893005},{"id":"https://openalex.org/keywords/collateral-vessel-formation","display_name":"collateral vessel formation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.989392876625061},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9160416126251221},{"id":"https://openalex.org/C2778844676","wikidata":"https://www.wikidata.org/wiki/Q190831","display_name":"Central retinal vein occlusion","level":4,"score":0.8122953176498413},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7727938294410706},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5764541625976562},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.5122339129447937},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.5024724006652832},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.336172491312027},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.33475953340530396},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.05583164095878601}],"mesh":[{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056965","descriptor_name":"Injections, Intraocular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s00417-021-05224-x","doi":"https://doi.org/10.1007/s00417-021-05224-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00417-021-05224-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00417-021-05224-x.pdf","source":{"id":"https://openalex.org/S93410275","display_name":"Graefe s Archive for Clinical and Experimental Ophthalmology","issn_l":"0721-832X","issn":["0721-832X","1435-702X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Graefe's Archive for Clinical and Experimental Ophthalmology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8850212","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8850212","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Graefes Arch Clin Exp Ophthalmol","raw_type":"Text"},{"id":"pmid:34613454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34613454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00417-021-05224-x","doi":"https://doi.org/10.1007/s00417-021-05224-x","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00417-021-05224-x","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00417-021-05224-x.pdf","source":{"id":"https://openalex.org/S93410275","display_name":"Graefe s Archive for Clinical and Experimental Ophthalmology","issn_l":"0721-832X","issn":["0721-832X","1435-702X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Graefe's Archive for Clinical and Experimental Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306811","display_name":"Research to Prevent Blindness","ror":"https://ror.org/04drjs621"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3203758519.pdf","grobid_xml":"https://content.openalex.org/works/W3203758519.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1967244076","https://openalex.org/W1978704499","https://openalex.org/W1983275936","https://openalex.org/W1999957425","https://openalex.org/W2034294591","https://openalex.org/W2034477424","https://openalex.org/W2035855497","https://openalex.org/W2052204551","https://openalex.org/W2057789225","https://openalex.org/W2057880134","https://openalex.org/W2058312539","https://openalex.org/W2064362164","https://openalex.org/W2083648307","https://openalex.org/W2084575920","https://openalex.org/W2087899702","https://openalex.org/W2089494988","https://openalex.org/W2102463203","https://openalex.org/W2103827117","https://openalex.org/W2107443927","https://openalex.org/W2128701654","https://openalex.org/W2137893922","https://openalex.org/W2142651474","https://openalex.org/W2144771657","https://openalex.org/W2155651989","https://openalex.org/W2166985747","https://openalex.org/W2178156144","https://openalex.org/W2594336900","https://openalex.org/W2612836720","https://openalex.org/W2616361514","https://openalex.org/W2801073872","https://openalex.org/W2894823502","https://openalex.org/W2909261967"],"related_works":["https://openalex.org/W2154763327","https://openalex.org/W4417412210","https://openalex.org/W4300373824","https://openalex.org/W2413880953","https://openalex.org/W2068100937","https://openalex.org/W7167741316","https://openalex.org/W2052204551","https://openalex.org/W1974243302","https://openalex.org/W4417235926","https://openalex.org/W2957558745"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"identify":[2],"anatomic":[3,92],"endpoints":[4,93],"altered":[5,94],"by":[6,95],"intravitreal":[7],"ranibizumab":[8,79,107],"in":[9,105,125,181,201,212,219,235],"central":[10,36],"retinal":[11,119,220],"vein":[12],"occlusion":[13],"(CRVO)":[14],"to":[15,68,89,115,196],"determine":[16],"any":[17],"potential":[18,91],"underlying":[19],"disease":[20],"modification":[21],"that":[22],"occurs":[23],"with":[24,60,110,113,247],"anti-vascular":[25],"endothelial":[26],"growth":[27],"factor":[28],"(anti-VEGF)":[29],"therapy":[30],"beyond":[31],"best-corrected":[32],"visual":[33],"acuity":[34],"and":[35,156,188,204,223],"optical":[37],"coherence":[38],"tomography":[39],"outcomes.":[40],"METHODS:":[41],"A":[42,55],"post":[43],"hoc":[44],"analysis":[45],"of":[46,57,73,78,118,142,158,186,199,238],"a":[47,103,217,239],"double-masked,":[48],"multicenter,":[49],"randomized":[50,66],"clinical":[51],"trial":[52],"was":[53,102,176],"performed.":[54],"total":[56,116],"392":[58],"patients":[59],"macular":[61],"edema":[62],"after":[63],"CRVO":[64,210],"were":[65,87],"1:1:1":[67],"receive":[69],"monthly":[70],"intraocular":[71],"injections":[72],"0.3":[74,134,150,166],"or":[75,80,242],"0.5":[76,139,154,170],"mg":[77],"sham":[81,111,205],"injections.":[82],"Central":[83],"reading":[84],"center-read":[85],"data":[86],"reviewed":[88],"explore":[90],"therapy.":[96],"RESULTS:":[97],"At":[98],"6":[99],"months,":[100],"there":[101],"reduction":[104,218],"the":[106,230,236],"groups":[108,112,180],"compared":[109],"respect":[114],"area":[117],"hemorrhage":[120,190],"(median":[121],"change":[122],"from":[123],"baseline":[124],"disc":[126,143],"areas:":[127],"-":[128,131,136],"1.17":[129],"[sham],":[130,147,163],"2.37":[132],"[ranibizumab":[133,138,149,153,165,169],"mg],":[135,151,167,171],"1.64":[137],"mg]),":[140,155],"development":[141,237],"neovascularization":[144],"(prevalence:":[145,161],"3%":[146],"0%":[148,152],"presence":[157],"papillary":[159,224],"swelling":[160],"22.9%":[162],"8.0%":[164],"8.3%":[168],"p":[172],"<":[173],"0.01).":[174],"There":[175],"no":[177],"difference":[178],"between":[179],"collateral":[182],"vessel":[183],"formation.":[184],"Analysis":[185],"vitreous":[187],"preretinal":[189],"could":[191],"not":[192],"be":[193],"performed":[194],"due":[195],"low":[197],"frequency":[198],"events":[200],"both":[202],"treated":[203],"groups.":[206],"CONCLUSIONS:":[207],"Ranibizumab":[208],"for":[209,232,245],"resulted":[211],"beneficial":[213],"disease-modifying":[214],"effects":[215],"through":[216],"hemorrhage,":[221],"neovascularization,":[222],"swelling.":[225],"These":[226],"findings":[227],"may":[228],"form":[229],"basis":[231],"future":[233],"work":[234],"treatment":[240],"response":[241],"severity":[243],"scale":[244],"eyes":[246],"CRVO.":[248]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-10-11T00:00:00"}